Genpact Limited (G) Shares Sold by Marathon Asset Management LLP

Marathon Asset Management LLP reduced its stake in shares of Genpact Limited (NYSE:G) by 0.5% during the first quarter, Holdings Channel reports. The fund owned 452,138 shares of the company’s stock after selling 2,310 shares during the period. Marathon Asset Management LLP owned about 0.23% of Genpact Limited worth $11,195,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in G. Rhumbline Advisers raised its position in shares of Genpact Limited by 3.1% in the third quarter. Rhumbline Advisers now owns 160,122 shares of the company’s stock valued at $3,835,000 after buying an additional 4,767 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Genpact Limited by 76.1% in the third quarter. TIAA CREF Investment Management LLC now owns 1,209,277 shares of the company’s stock valued at $28,962,000 after buying an additional 522,387 shares during the last quarter. Teachers Advisors LLC raised its position in shares of Genpact Limited by 13.9% in the third quarter. Teachers Advisors LLC now owns 141,471 shares of the company’s stock valued at $3,388,000 after buying an additional 17,223 shares during the last quarter. New York State Common Retirement Fund raised its position in shares of Genpact Limited by 16.0% in the third quarter. New York State Common Retirement Fund now owns 576,305 shares of the company’s stock valued at $13,803,000 after buying an additional 79,413 shares during the last quarter. Finally, BlackRock Fund Advisors raised its position in shares of Genpact Limited by 1.4% in the third quarter. BlackRock Fund Advisors now owns 1,474,329 shares of the company’s stock valued at $35,310,000 after buying an additional 20,316 shares during the last quarter. 90.37% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Genpact Limited (NYSE:G)

Genpact Limited (NYSE:G) traded down 0.62% during trading on Thursday, reaching $23.87. 260,859 shares of the company’s stock were exchanged. The stock has a market capitalization of $4.75 billion, a PE ratio of 18.65 and a beta of 0.63. Genpact Limited has a 52 week low of $22.58 and a 52 week high of $28.52. The stock has a 50-day moving average of $24.18 and a 200-day moving average of $24.07.

Genpact Limited (NYSE:G) last announced its quarterly earnings data on Friday, February 10th. The company reported $0.43 EPS for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.04. Genpact Limited had a return on equity of 21.52% and a net margin of 10.49%. The business earned $682 million during the quarter, compared to the consensus estimate of $684.81 million. During the same period in the previous year, the company posted $0.34 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, equities research analysts anticipate that Genpact Limited will post $1.55 EPS for the current year.

The business also recently disclosed a special dividend, which was paid on Tuesday, March 28th. Stockholders of record on Friday, March 10th were given a dividend of $0.06 per share. The ex-dividend date was Wednesday, March 8th.

ILLEGAL ACTIVITY NOTICE: “Genpact Limited (G) Shares Sold by Marathon Asset Management LLP” was first reported by sleekmoney and is the property of of sleekmoney. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at http://sleekmoney.com/genpact-limited-g-shares-sold-by-marathon-asset-management-llp/1739147.html.

Several equities analysts recently commented on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $27.00 price objective on shares of Genpact Limited in a research report on Friday, February 10th. Zacks Investment Research raised shares of Genpact Limited from a “sell” rating to a “hold” rating in a research report on Thursday, January 5th. Jefferies Group LLC reaffirmed a “buy” rating on shares of Genpact Limited in a research report on Friday, March 17th. Finally, BMO Capital Markets reaffirmed a “hold” rating and issued a $25.00 price objective on shares of Genpact Limited in a research report on Thursday, March 23rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company’s stock. Genpact Limited currently has an average rating of “Buy” and an average target price of $28.38.

In other news, insider Mohit Thukral sold 10,000 shares of the business’s stock in a transaction dated Wednesday, January 25th. The stock was sold at an average price of $24.50, for a total transaction of $245,000.00. Following the completion of the transaction, the insider now directly owns 70,305 shares of the company’s stock, valued at $1,722,472.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider N. V. Tyagarajan sold 198,642 shares of the business’s stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $24.09, for a total value of $4,785,285.78. Following the transaction, the insider now directly owns 477,787 shares of the company’s stock, valued at $11,509,888.83. The disclosure for this sale can be found here. Over the last three months, insiders have sold 238,642 shares of company stock valued at $5,770,986. Corporate insiders own 1.55% of the company’s stock.

Genpact Limited Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

5 Day Chart for NYSE:G

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/genpact-limited-g-shares-sold-by-marathon-asset-management-llp/1739147.html

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *